Multiple Sclerosis : : Diagnosis and Treatment II / / Víctor M. Rivera.

The book "Multiple Sclerosis: Diagnosis and Treatment" provides a collection of selected articles published in Biomedicines as part of Volume II addressing current issues on this major inflammatory demyelinating neurological disorder. The articles describe recent advances and discoveries i...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
Place / Publishing House:Basel, Switzerland : : MDPI - Multidisciplinary Digital Publishing Institute,, 2022.
Year of Publication:2022
Language:English
Physical Description:1 online resource (160 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993562102604498
ctrlnum (CKB)4920000001372702
(NjHacI)994920000001372702
(EXLCZ)994920000001372702
collection bib_alma
record_format marc
spelling Rivera, Víctor M., author.
Multiple Sclerosis : Diagnosis and Treatment II / Víctor M. Rivera.
Multiple Sclerosis
Basel, Switzerland : MDPI - Multidisciplinary Digital Publishing Institute, 2022.
1 online resource (160 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
The book "Multiple Sclerosis: Diagnosis and Treatment" provides a collection of selected articles published in Biomedicines as part of Volume II addressing current issues on this major inflammatory demyelinating neurological disorder. The articles describe recent advances and discoveries in the molecular and cell microenvironment contributing to neuro-inflammation in the brain and spinal cord. The role of the neurofilaments light chain as a serological biomarker of axonal and neuronal degeneration of the CNS is presented not just as a sensitive diagnostic tool, but also as an indicator of treatment responses. The new generation of therapeutic molecules belonging to the sphingosine-1-phosphate class are discussed, and their potential as disease-modifying treatment is considered. Investigations into the intimate molecular mechanisms of highly active MS, disclosed clinically and by MRI, are discussed by researchers proposing that the expression of RNAs in peripheral blood cells is a biomarker of highly active disease. The book also addresses important clinical and epidemiological aspects of pediatric MS and that in multi-ethnic cohorts.
About the Editor ii -- Victor M. Rivera Editorial of Special Issue "Multiple Sclerosis: Diagnosis and Treatment II" Reprinted from: Biomedicines 2021, 9, 1605, doi:10.3390/biomedicines9111605 1 -- Valentina Gatta, Guadalupe Mengod, Marcella Reale and Ada Maria Tata Possible Correlation between Cholinergic System Alterations and Neuro/Inflammation in Multiple Sclerosis Reprinted from: Biomedicines 2020, 8, 153, doi:10.3390/biomedicines8060153 7 -- Domenico De Rasmo, Anna Ferretta, Silvia Russo, Maddalena Ruggieri, Piergiorgio Lasorella, Damiano Paolicelli, Maria Trojano and Anna Signorile PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels Reprinted from: Biomedicines 2020, 8, 85, doi:10.3390/biomedicines8040085 23 -- Vicki Mercado, Deepa Dongarwar, Kristen Fisher, Hamisu M. Salihu, George J. Hutton and Fernando X. Cuascut Multiple Sclerosis in a Multi-Ethnic Population in Houston, Texas: A Retrospective Analysis Reprinted from: Biomedicines 2020, 8, 534, doi:10.3390/biomedicines8120534 35 -- Simon Thebault, Ronald A. Booth and Mark S. Freedman Blood Neurofilament Light Chain: The Neurologist's Troponin? Reprinted from: Biomedicines 2020, 8, 523, doi:10.3390/biomedicines8110523 47 -- Mariano Marrodan, Mar´ıa I. Gait´an and Jorge Correale Spinal Cord Involvement in MS and Other Demyelinating Diseases Reprinted from: Biomedicines 2020, 8, 130, doi:10.3390/biomedicines8050130 59 -- Stanley Cohan, Elisabeth Lucassen, Kyle Smoot, Justine Brink and Chiayi Chen Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article Reprinted from: Biomedicines 2020, 8, 227, doi:10.3390/biomedicines8070227 85 -- Andr´e Huss, Makbule Senel, Ahmed Abdelhak, Benjamin Mayer, Jan Kassubek, Albert C. Ludolph, Markus Otto and Hayrettin Tumani Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies Reprinted from: Biomedicines 2020, 8, 312, doi:10.3390/biomedicines8090312 109 -- Leire Iparraguirre, Danel Olaverri, Telmo Blasco, Luc´ıa Sep´ulveda, Tamara Castillo-Trivi˜no, Mercedes Espi˜no, Lucienne Costa-Frossard, ´Alvaro Prada, Luisa Mar´ıa Villar, David Otaegui and Maider Mu˜noz-Culla Whole-Transcriptome Analysis in Peripheral Blood Mononuclear Cells from Patients with Lipid-Specific Oligoclonal IgM Band Characterization Reveals Two Circular RNAs and Two Linear RNAs as Biomarkers of Highly Active Disease Reprinted from: Biomedicines 2020, 8, 540, doi:10.3390/biomedicines8120540 121 -- Kristen S. Fisher, Fernando X. Cuascut, Victor M. Rivera and George J. Hutton Current Advances in Pediatric Onset Multiple Sclerosis Reprinted from: Biomedicines 2020, 8, 71, doi:10.3390/biomedicines8040071 137.
Multiple sclerosis.
Multiple sclerosis Treatment.
3-0365-2917-9
language English
format eBook
author Rivera, Víctor M.,
spellingShingle Rivera, Víctor M.,
Multiple Sclerosis : Diagnosis and Treatment II /
About the Editor ii -- Victor M. Rivera Editorial of Special Issue "Multiple Sclerosis: Diagnosis and Treatment II" Reprinted from: Biomedicines 2021, 9, 1605, doi:10.3390/biomedicines9111605 1 -- Valentina Gatta, Guadalupe Mengod, Marcella Reale and Ada Maria Tata Possible Correlation between Cholinergic System Alterations and Neuro/Inflammation in Multiple Sclerosis Reprinted from: Biomedicines 2020, 8, 153, doi:10.3390/biomedicines8060153 7 -- Domenico De Rasmo, Anna Ferretta, Silvia Russo, Maddalena Ruggieri, Piergiorgio Lasorella, Damiano Paolicelli, Maria Trojano and Anna Signorile PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels Reprinted from: Biomedicines 2020, 8, 85, doi:10.3390/biomedicines8040085 23 -- Vicki Mercado, Deepa Dongarwar, Kristen Fisher, Hamisu M. Salihu, George J. Hutton and Fernando X. Cuascut Multiple Sclerosis in a Multi-Ethnic Population in Houston, Texas: A Retrospective Analysis Reprinted from: Biomedicines 2020, 8, 534, doi:10.3390/biomedicines8120534 35 -- Simon Thebault, Ronald A. Booth and Mark S. Freedman Blood Neurofilament Light Chain: The Neurologist's Troponin? Reprinted from: Biomedicines 2020, 8, 523, doi:10.3390/biomedicines8110523 47 -- Mariano Marrodan, Mar´ıa I. Gait´an and Jorge Correale Spinal Cord Involvement in MS and Other Demyelinating Diseases Reprinted from: Biomedicines 2020, 8, 130, doi:10.3390/biomedicines8050130 59 -- Stanley Cohan, Elisabeth Lucassen, Kyle Smoot, Justine Brink and Chiayi Chen Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article Reprinted from: Biomedicines 2020, 8, 227, doi:10.3390/biomedicines8070227 85 -- Andr´e Huss, Makbule Senel, Ahmed Abdelhak, Benjamin Mayer, Jan Kassubek, Albert C. Ludolph, Markus Otto and Hayrettin Tumani Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies Reprinted from: Biomedicines 2020, 8, 312, doi:10.3390/biomedicines8090312 109 -- Leire Iparraguirre, Danel Olaverri, Telmo Blasco, Luc´ıa Sep´ulveda, Tamara Castillo-Trivi˜no, Mercedes Espi˜no, Lucienne Costa-Frossard, ´Alvaro Prada, Luisa Mar´ıa Villar, David Otaegui and Maider Mu˜noz-Culla Whole-Transcriptome Analysis in Peripheral Blood Mononuclear Cells from Patients with Lipid-Specific Oligoclonal IgM Band Characterization Reveals Two Circular RNAs and Two Linear RNAs as Biomarkers of Highly Active Disease Reprinted from: Biomedicines 2020, 8, 540, doi:10.3390/biomedicines8120540 121 -- Kristen S. Fisher, Fernando X. Cuascut, Victor M. Rivera and George J. Hutton Current Advances in Pediatric Onset Multiple Sclerosis Reprinted from: Biomedicines 2020, 8, 71, doi:10.3390/biomedicines8040071 137.
author_facet Rivera, Víctor M.,
author_variant v m r vm vmr
author_role VerfasserIn
author_sort Rivera, Víctor M.,
title Multiple Sclerosis : Diagnosis and Treatment II /
title_sub Diagnosis and Treatment II /
title_full Multiple Sclerosis : Diagnosis and Treatment II / Víctor M. Rivera.
title_fullStr Multiple Sclerosis : Diagnosis and Treatment II / Víctor M. Rivera.
title_full_unstemmed Multiple Sclerosis : Diagnosis and Treatment II / Víctor M. Rivera.
title_auth Multiple Sclerosis : Diagnosis and Treatment II /
title_alt Multiple Sclerosis
title_new Multiple Sclerosis :
title_sort multiple sclerosis : diagnosis and treatment ii /
publisher MDPI - Multidisciplinary Digital Publishing Institute,
publishDate 2022
physical 1 online resource (160 pages)
contents About the Editor ii -- Victor M. Rivera Editorial of Special Issue "Multiple Sclerosis: Diagnosis and Treatment II" Reprinted from: Biomedicines 2021, 9, 1605, doi:10.3390/biomedicines9111605 1 -- Valentina Gatta, Guadalupe Mengod, Marcella Reale and Ada Maria Tata Possible Correlation between Cholinergic System Alterations and Neuro/Inflammation in Multiple Sclerosis Reprinted from: Biomedicines 2020, 8, 153, doi:10.3390/biomedicines8060153 7 -- Domenico De Rasmo, Anna Ferretta, Silvia Russo, Maddalena Ruggieri, Piergiorgio Lasorella, Damiano Paolicelli, Maria Trojano and Anna Signorile PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels Reprinted from: Biomedicines 2020, 8, 85, doi:10.3390/biomedicines8040085 23 -- Vicki Mercado, Deepa Dongarwar, Kristen Fisher, Hamisu M. Salihu, George J. Hutton and Fernando X. Cuascut Multiple Sclerosis in a Multi-Ethnic Population in Houston, Texas: A Retrospective Analysis Reprinted from: Biomedicines 2020, 8, 534, doi:10.3390/biomedicines8120534 35 -- Simon Thebault, Ronald A. Booth and Mark S. Freedman Blood Neurofilament Light Chain: The Neurologist's Troponin? Reprinted from: Biomedicines 2020, 8, 523, doi:10.3390/biomedicines8110523 47 -- Mariano Marrodan, Mar´ıa I. Gait´an and Jorge Correale Spinal Cord Involvement in MS and Other Demyelinating Diseases Reprinted from: Biomedicines 2020, 8, 130, doi:10.3390/biomedicines8050130 59 -- Stanley Cohan, Elisabeth Lucassen, Kyle Smoot, Justine Brink and Chiayi Chen Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article Reprinted from: Biomedicines 2020, 8, 227, doi:10.3390/biomedicines8070227 85 -- Andr´e Huss, Makbule Senel, Ahmed Abdelhak, Benjamin Mayer, Jan Kassubek, Albert C. Ludolph, Markus Otto and Hayrettin Tumani Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies Reprinted from: Biomedicines 2020, 8, 312, doi:10.3390/biomedicines8090312 109 -- Leire Iparraguirre, Danel Olaverri, Telmo Blasco, Luc´ıa Sep´ulveda, Tamara Castillo-Trivi˜no, Mercedes Espi˜no, Lucienne Costa-Frossard, ´Alvaro Prada, Luisa Mar´ıa Villar, David Otaegui and Maider Mu˜noz-Culla Whole-Transcriptome Analysis in Peripheral Blood Mononuclear Cells from Patients with Lipid-Specific Oligoclonal IgM Band Characterization Reveals Two Circular RNAs and Two Linear RNAs as Biomarkers of Highly Active Disease Reprinted from: Biomedicines 2020, 8, 540, doi:10.3390/biomedicines8120540 121 -- Kristen S. Fisher, Fernando X. Cuascut, Victor M. Rivera and George J. Hutton Current Advances in Pediatric Onset Multiple Sclerosis Reprinted from: Biomedicines 2020, 8, 71, doi:10.3390/biomedicines8040071 137.
isbn 3-0365-2917-9
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC377
callnumber-sort RC 3377 R584 42022
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.83406
dewey-sort 3616.83406
dewey-raw 616.83406
dewey-search 616.83406
work_keys_str_mv AT riveravictorm multiplesclerosisdiagnosisandtreatmentii
AT riveravictorm multiplesclerosis
status_str n
ids_txt_mv (CKB)4920000001372702
(NjHacI)994920000001372702
(EXLCZ)994920000001372702
carrierType_str_mv cr
is_hierarchy_title Multiple Sclerosis : Diagnosis and Treatment II /
_version_ 1764992861369008128
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02128nam a2200289 i 4500</leader><controlfield tag="001">993562102604498</controlfield><controlfield tag="005">20230330100841.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230330s2022 sz o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000001372702</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994920000001372702</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000001372702</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC377</subfield><subfield code="b">.R584 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.83406</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Rivera, Víctor M.,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Multiple Sclerosis :</subfield><subfield code="b">Diagnosis and Treatment II /</subfield><subfield code="c">Víctor M. Rivera.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Multiple Sclerosis </subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel, Switzerland :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (160 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The book "Multiple Sclerosis: Diagnosis and Treatment" provides a collection of selected articles published in Biomedicines as part of Volume II addressing current issues on this major inflammatory demyelinating neurological disorder. The articles describe recent advances and discoveries in the molecular and cell microenvironment contributing to neuro-inflammation in the brain and spinal cord. The role of the neurofilaments light chain as a serological biomarker of axonal and neuronal degeneration of the CNS is presented not just as a sensitive diagnostic tool, but also as an indicator of treatment responses. The new generation of therapeutic molecules belonging to the sphingosine-1-phosphate class are discussed, and their potential as disease-modifying treatment is considered. Investigations into the intimate molecular mechanisms of highly active MS, disclosed clinically and by MRI, are discussed by researchers proposing that the expression of RNAs in peripheral blood cells is a biomarker of highly active disease. The book also addresses important clinical and epidemiological aspects of pediatric MS and that in multi-ethnic cohorts.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">About the Editor ii -- Victor M. Rivera Editorial of Special Issue "Multiple Sclerosis: Diagnosis and Treatment II" Reprinted from: Biomedicines 2021, 9, 1605, doi:10.3390/biomedicines9111605 1 -- Valentina Gatta, Guadalupe Mengod, Marcella Reale and Ada Maria Tata Possible Correlation between Cholinergic System Alterations and Neuro/Inflammation in Multiple Sclerosis Reprinted from: Biomedicines 2020, 8, 153, doi:10.3390/biomedicines8060153 7 -- Domenico De Rasmo, Anna Ferretta, Silvia Russo, Maddalena Ruggieri, Piergiorgio Lasorella, Damiano Paolicelli, Maria Trojano and Anna Signorile PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels Reprinted from: Biomedicines 2020, 8, 85, doi:10.3390/biomedicines8040085 23 -- Vicki Mercado, Deepa Dongarwar, Kristen Fisher, Hamisu M. Salihu, George J. Hutton and Fernando X. Cuascut Multiple Sclerosis in a Multi-Ethnic Population in Houston, Texas: A Retrospective Analysis Reprinted from: Biomedicines 2020, 8, 534, doi:10.3390/biomedicines8120534 35 -- Simon Thebault, Ronald A. Booth and Mark S. Freedman Blood Neurofilament Light Chain: The Neurologist's Troponin? Reprinted from: Biomedicines 2020, 8, 523, doi:10.3390/biomedicines8110523 47 -- Mariano Marrodan, Mar´ıa I. Gait´an and Jorge Correale Spinal Cord Involvement in MS and Other Demyelinating Diseases Reprinted from: Biomedicines 2020, 8, 130, doi:10.3390/biomedicines8050130 59 -- Stanley Cohan, Elisabeth Lucassen, Kyle Smoot, Justine Brink and Chiayi Chen Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article Reprinted from: Biomedicines 2020, 8, 227, doi:10.3390/biomedicines8070227 85 -- Andr´e Huss, Makbule Senel, Ahmed Abdelhak, Benjamin Mayer, Jan Kassubek, Albert C. Ludolph, Markus Otto and Hayrettin Tumani Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies Reprinted from: Biomedicines 2020, 8, 312, doi:10.3390/biomedicines8090312 109 -- Leire Iparraguirre, Danel Olaverri, Telmo Blasco, Luc´ıa Sep´ulveda, Tamara Castillo-Trivi˜no, Mercedes Espi˜no, Lucienne Costa-Frossard, ´Alvaro Prada, Luisa Mar´ıa Villar, David Otaegui and Maider Mu˜noz-Culla Whole-Transcriptome Analysis in Peripheral Blood Mononuclear Cells from Patients with Lipid-Specific Oligoclonal IgM Band Characterization Reveals Two Circular RNAs and Two Linear RNAs as Biomarkers of Highly Active Disease Reprinted from: Biomedicines 2020, 8, 540, doi:10.3390/biomedicines8120540 121 -- Kristen S. Fisher, Fernando X. Cuascut, Victor M. Rivera and George J. Hutton Current Advances in Pediatric Onset Multiple Sclerosis Reprinted from: Biomedicines 2020, 8, 71, doi:10.3390/biomedicines8040071 137.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Multiple sclerosis.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Multiple sclerosis</subfield><subfield code="x">Treatment.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-2917-9</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-04-15 12:52:28 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-09-22 08:09:39 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337971840004498&amp;Force_direct=true</subfield><subfield code="Z">5337971840004498</subfield><subfield code="8">5337971840004498</subfield></datafield></record></collection>